由首次对强的松龙治疗反应来验证微小病变型肾病综合征。对原发肾病综合征患儿应尽可能在病程的早期即鉴别其是微小病变型(以下简称MCNS)还是另一些肾小球病变,因为此关系到患儿是否需要肾活检,制订何种最合适的初步治疗和予示其预后的好坏。许多有经验的临床医生很有把握地在病程早期能做出此种重要的鉴别诊断,尤其是通过观察肾上腺皮质激素的首次强化治疗反应,更加能做出鉴别来。但是,还不大清楚这种推测的准确性。国际儿童肾脏病研究的这篇报告是一展望性的有 Micro-lesion nephrotic syndrome was validated by the first response to prednisolone treatment. Children with primary nephrotic syndrome should be as early as possible in the course of the disease that is identified as minor lesions (MCNS) or other glomerular lesions, because it is related to whether the children need renal biopsy, what is the most developed The appropriate initial treatment and to show the prognosis of good or bad. Many experienced clinicians are confident that such important differential diagnoses can be made early in the course of their disease, and more specifically by first adrenocorticotropic hormone treatment. However, it is unclear how accurate this speculation is. This report of the International Kidney Disease Study is a promising one